P
Panayiotis G. Vlachoyiannopoulos
Researcher at National and Kapodistrian University of Athens
Publications - 139
Citations - 11053
Panayiotis G. Vlachoyiannopoulos is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Antiphospholipid syndrome & Medicine. The author has an hindex of 38, co-authored 117 publications receiving 9414 citations. Previous affiliations of Panayiotis G. Vlachoyiannopoulos include University of Pisa.
Papers
More filters
Journal ArticleDOI
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
Spiros Miyakis,Michael D. Lockshin,Tatsuya Atsumi,D W Branch,Robin L. Brey,Ricard Cervera,R. H. W. M. Derksen,P. G. De Groot,Takao Koike,Pier Luigi Meroni,Guido Reber,Yehuda Shoenfeld,Angela Tincani,Panayiotis G. Vlachoyiannopoulos,Steven A. Krilis +14 more
TL;DR: This document appraise the existing evidence on clinical and laboratory features of APS addressed during the forum and proposes amendments to the Sapporo criteria, including definitions on features ofAPS that were not included in the updated criteria.
Journal ArticleDOI
Mortality in systemic sclerosis: An international meta-analysis of individual patient data
John P. A. Ioannidis,John P. A. Ioannidis,Panayiotis G. Vlachoyiannopoulos,Anna-Bettina Haidich,Thomas A. Medsger,Mary Lucas,Clement J. Michet,Masataka Kuwana,Hidekata Yasuoka,Frank J. A. van den Hoogen,Liane te Boome,Jacob M van Laar,Nicolette L. Verbeet,Marco Matucci-Cerinic,Athanasios Georgountzos,Haralampos M. Moutsopoulos +15 more
TL;DR: In this article, a meta-analysis of individual patient data from cohorts recruited from seven medical centers in the United States, Europe, and Japan, using standardized definitions for disease subtype and organ system involvement was performed.
Journal ArticleDOI
Mapping and predicting mortality from systemic sclerosis
Muriel Elhai,Christophe Meune,Marouane Boubaya,Jérôme Avouac,Eric Hachulla,Alexandra Balbir-Gurman,Gabriela Riemekasten,Paolo Airò,Beatriz Joven,Serena Vettori,Franco Cozzi,Susanne Ullman,László Czirják,Mohammed Tikly,Ulf Müller-Ladner,Paola Caramaschi,Oliver Distler,Florenzo Iannone,L. Ananieva,Roger Hesselstrand,R. Becvar,Armando Gabrielli,Nemanja Damjanov,Maria João Salvador,Valeria Riccieri,Carina Mihai,Gabriella Szücs,Ulrich A Walker,Nicolas Hunzelmann,Duska Martinovic,Vanessa Smith,Carolina de Souza Müller,Carlomaurizio Montecucco,Daniela Opris,Francesca Ingegnoli,Panayiotis G. Vlachoyiannopoulos,Bojana Stamenkovic,Edoardo Rosato,Stefan Heitmann,Jörg H W Distler,Thierry Zenone,Matthias Seidel,Alessandra Vacca,Ellen De Langhe,Srdan Novak,Maurizio Cutolo,Luc Mouthon,Jörg Henes,Carlo Chizzolini,Carlos Alberto Von Mühlen,Kamal Solanki,Simona Rednic,Lisa K. Stamp,Branimir Anić,Branimir Anić,Vera Ortiz Santamaria,Maria De Santis,Sule Yavuz,Walter Alberto Sifuentes-Giraldo,Emmanuel Chatelus,Jiri Stork,Jacob M van Laar,Esthela Loyo,Paloma García de la Peña Lefebvre,Kilian Eyerich,Vanesa Cosentino,Juan José Alegre-Sancho,Otylia Kowal-Bielecka,Grégoire Rey,Marco Matucci-Cerinic,Yannick Allanore +70 more
TL;DR: Combining two complementary and detailed databases enabled the collection of an unprecedented 3700 deaths, revealing the major contribution of the cardiopulmonary system to SSc mortality.
Journal ArticleDOI
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Dinesh Khanna,Celia J. F. Lin,Daniel E. Furst,Jonathan G. Goldin,Grace Kim,Masataka Kuwana,Yannick Allanore,Marco Matucci-Cerinic,Oliver Distler,Yoshihito Shima,Jacob M van Laar,Helen Spotswood,Bridget Wagner,Jeffrey Siegel,Angelika Jahreis,Christopher P. Denton,Eleonora Lucero,Bernardo A. Pons-Estel,Mariano Rivero,Guillermo Tate,Vanessa Smith,Ellen De Langhe,Rasho Rashkov,Anastas Batalov,Ivan Goranov,Rumen Stoilov,James V. Dunne,Sindhu R. Johnson,Janet E. Pope,Dušanka Martinović Kaliterna,Mette Mogensen,Anne Braae Olesen,Joerg Henes,Ulf Müller-Ladner,Gabriela Riemekasten,Alla Skapenko,Panayiotis G. Vlachoyiannopoulos,Emese Kiss,Tünde Minier,Lorenzo Beretta,Elisa Gremese,Gabriele Valentini,Yoshihide Asano,Tatsuya Atsumi,Hironobu Ihn,Tomonori Ishii,Osamu Ishikawa,Hiroki Takahashi,Kazuhiko Takehara,Yoshiya Tanaka,Yoshioki Yamasaki,Loreta Bukauskiene,Irena Butrimiene,Gabriel Medrano Ramirez,Cesar Ramos-Remus,Tatiana Sofia Rodriguez Reyna,Jeska K de Vries-Bouwstra,Bogdan Batko,Sławomir Jeka,Eugeniusz J. Kucharz,Maria Majdan,Marzena Olesińska,Zaneta Smolenska,Jose Alves,Maria José Santos,C. Mihai,Simona Rednic,Ivan Castellvi Barranco,Francisco Javier Lopez Longo,Carmen Simeon Aznar,Patricia Carreira,Ulrich A. Walker,Emma Derrett-Smith,Bridget Griffiths,Neil McKay,Jacob Aelion,Michael S. Borofsky,Roy Fleischmann,Joseph Z. Forstot,Suzanne Kafaja,M. Faisal Khan,Michael D. Kohen,Richard J. Martin,Fabian Mendoza-Ballesteros,Alireza Nami,Shirley Pang,Grissel Rios,Robert W. Simms,Keith M. Sullivan,Virginia D. Steen +89 more
TL;DR: Findings for the secondary endpoint of FVC% predicted indicate that tocilizumab might preserve lung function in people with early SSc-ILD and elevated acute-phase reactants.
Journal ArticleDOI
Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.
Johannes C. Nossent,Nada Čikeš,Emese Kiss,Antonio Marchesoni,V. Nassonova,Marta Mosca,Marzena Olesińska,G. Pokorny,Blaž Rozman,Matthias Schneider,Panayiotis G. Vlachoyiannopoulos,A. J. G. Swaak +11 more
TL;DR: The bimodal mortality curve has flattened out and deaths now occur evenly throughout the disease course with infectious and cardiovascular complications as the main direct COD in both early and late fatalities.